| | 1361224-53-4 Basic information More.. |
| Product Name: | AMG-3969 | | Synonyms: | AMG-3969;CS-2503;AMG-3969; AMG 3969; AMG3969;Benzenemethanol, 4-[(2S)-4-[(6-amino-3-pyridinyl)sulfonyl]-2-(1-propyn-1-yl)-1-piperazinyl]-α,α-bis(trifluoromethyl)-;(S)-2-(4-(4-((6-Aminopyridin-3-yl)sulfonyl)-2-(prop-1-yn-1-yl)piperazin-1-yl)phenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol;Hexokinase IV,AMG 3969,Hexokinase D,Glucokinase,Inhibitor,AMG3969,AMG-3969,inhibit;2-[4-[(2S)-4-[(6-amino-3-pyridyl)sulfonyl]-2-prop-1-ynyl-piperazin-1-yl]phenyl]-1,1,1,3,3,3-hexafluoro-propan-2-ol;AMG-3969, 10 mM in DMSO | | CAS: | 1361224-53-4 | | MF: | C21H20F6N4O3S | | MW: | 522.46 | | EINECS: | | | Mol File: | 1361224-53-4.mol |  |
Use
Lloyd, David J., et al. Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors. Nature 504.7480(2013):437-40.
Bourbeau, M. P., et al. Nonracemic synthesis of GK-GKRP disruptor AMG-3969. Synfacts 79.8(2014):3684.
http://www.metonchem.com/products/amg-3969-cas1361224-53-4/
- AMG-3969
-
- US $105.00-388.00 / mg
- 2025-06-12
- CAS:1361224-53-4
- Min. Order:
- Purity: 99.65%
- Supply Ability: 10g
|
|
1361224-53-4
Recommend Suppliers |
|